New Jersey A 2330: Requires Medicaid preferred drug lists to provide for coverage of buprenorphine for treatment of chronic pain.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-02-03)

State: New Jersey · Session: 219 · Bill: A 2330

Subjects: MEDICAID, PHARMACEUTIC

Sponsors: Murphy, Carol A., Vainieri Huttle, Valerie

View New Jersey A 2330 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.